Intravenous Immunoglobulin Therapy in Children Vasculitis: A Systematic Review

  • سال انتشار: 1404
  • محل انتشار: فصلنامه علم و فناوری اوراسیا، دوره: 5، شماره: 1
  • کد COI اختصاصی: JR_EJST-5-1_002
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 129
دانلود فایل این مقاله

نویسندگان

Leila Mahboobi

Department of Pediatrics, Tabriz University of Medical Sciences, Tabriz, Iran

Babak Sandoghchian Shotorbani

Department of Pediatrics, Ardabil University of Medical Sciences, Ardabil, Iran

چکیده

Introduction: IVIG therapy represents a valuable therapeutic option in the management of pediatric vasculitis, offering immunomodulatory effects, and favorable safety outcomes. By targeting multiple pathogenic pathways implicated in vasculitic disease processes, IVIG helps alleviate inflammation, reduce disease activity, and improve clinical outcomes in affected children.Material and methods: Two independent reviewers screened the titles and abstracts of retrieved articles to assess eligibility based on the predefined inclusion and exclusion criteria. Full-text articles of potentially relevant studies were then obtained and assessed for final inclusion. Data extraction was performed using a standardized form, capturing relevant information such as study characteristics (author, publication year, study design), patient demographics, vasculitis subtype, IVIG regimen (dosage, duration), primary and secondary outcomes, adverse events, and follow-up duration.Results: Across the included studies, IVIG therapy demonstrated favorable treatment outcomes in pediatric patients with various forms of vasculitis. The most common vasculitis types investigated were Kawasaki disease, Henoch-Schönlein purpura, Takayasu arteritis, and polyarteritis nodosa.Conclusion: IVIG therapy represents a valuable treatment modality for children with vasculitis, offering immunomodulatory effects that can attenuate inflammation, preserve organ function, and improve clinical outcomes. The mechanisms of action of IVIG involve modulation of the immune response, inhibition of autoantibody production, and restoration of immune homeostasis.

کلیدواژه ها

IVIG therapy, vasculitis, children, Systematic review

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.